{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/suxamethonium",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769199",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769199_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"amikacin\" outputclass=\"int-drug\">amikacin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  amikacin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amikacin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769200",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769200_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"atracurium\" outputclass=\"int-drug\">atracurium</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  atracurium  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769201",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769201_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"beclometasone\" outputclass=\"int-drug\">Beclometasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Beclometasone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Beclometasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769202",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769202_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"betamethasone\" outputclass=\"int-drug\">Betamethasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Betamethasone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769203",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769203_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"botulinum toxin type A\" outputclass=\"int-drug\">botulinum toxin type A</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  botulinum toxin type A  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Botulinum toxin type A</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769204",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769204_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"botulinum toxin type B\" outputclass=\"int-drug\">botulinum toxin type B</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  botulinum toxin type B  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Botulinum toxin type B</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769205",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769205_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"budesonide\" outputclass=\"int-drug\">Budesonide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Budesonide   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Budesonide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769206",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769206_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"carbamazepine\" outputclass=\"int-drug\">Carbamazepine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Carbamazepine   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carbamazepine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769207",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769207_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"ciclesonide\" outputclass=\"int-drug\">Ciclesonide</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Ciclesonide   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ciclesonide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769208",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769208_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"cisatracurium\" outputclass=\"int-drug\">cisatracurium</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  cisatracurium  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cisatracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769209",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769209_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"citalopram\" outputclass=\"int-drug\">Citalopram</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Citalopram   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Citalopram</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769210",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769210_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"clindamycin\" outputclass=\"int-drug\">Clindamycin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Clindamycin   increases   the effects of   suxamethonium .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clindamycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769211",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769211_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"colistimethate\" outputclass=\"int-drug\">colistimethate</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  colistimethate  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Colistimethate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769212",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769212_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"cyclophosphamide\" outputclass=\"int-drug\">Cyclophosphamide</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Cyclophosphamide   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cyclophosphamide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769213",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769213_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"dapoxetine\" outputclass=\"int-drug\">Dapoxetine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Dapoxetine   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dapoxetine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769214",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769214_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"deflazacort\" outputclass=\"int-drug\">Deflazacort</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Deflazacort   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Deflazacort</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769215",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769215_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"dexamethasone\" outputclass=\"int-drug\">Dexamethasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Dexamethasone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Dexamethasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769216",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769216_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">Suxamethonium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of cardiovascular side-effects when given with</ph> <ph otherprops=\"digoxin\" outputclass=\"int-drug\">digoxin</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Suxamethonium   is predicted to   increase   the risk of cardiovascular side-effects when given with   digoxin .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Digoxin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769217",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769217_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"donepezil\" outputclass=\"int-drug\">Donepezil</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Donepezil   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Donepezil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769218",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769218_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"escitalopram\" outputclass=\"int-drug\">Escitalopram</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Escitalopram   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Escitalopram</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769219",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769219_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fludrocortisone\" outputclass=\"int-drug\">Fludrocortisone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fludrocortisone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fludrocortisone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769220",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769220_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"fluoxetine\" outputclass=\"int-drug\">Fluoxetine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Fluoxetine   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluoxetine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769221",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769221_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"fluticasone\" outputclass=\"int-drug\">Fluticasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Fluticasone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluticasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769222",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769222_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"fluvoxamine\" outputclass=\"int-drug\">Fluvoxamine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Fluvoxamine   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fluvoxamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769223",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769223_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"fosphenytoin\" outputclass=\"int-drug\">Fosphenytoin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Fosphenytoin   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fosphenytoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769224",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769224_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"galantamine\" outputclass=\"int-drug\">Galantamine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Galantamine   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Galantamine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769225",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769225_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"gentamicin\" outputclass=\"int-drug\">gentamicin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  gentamicin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Gentamicin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769226",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769226_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"hydrocortisone\" outputclass=\"int-drug\">Hydrocortisone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Hydrocortisone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Hydrocortisone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769227",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769227_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"irinotecan\" outputclass=\"int-drug\">Irinotecan</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Irinotecan   is predicted to   increase   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Irinotecan</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769228",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769228_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"lidocaine\" outputclass=\"int-drug\">Lidocaine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Lidocaine   is predicted to   increase   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Lidocaine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769229",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769229_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Intravenous</ph> <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Intravenous   magnesium   is predicted to   increase   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769230",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769230_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"methylprednisolone\" outputclass=\"int-drug\">Methylprednisolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Methylprednisolone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methylprednisolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769231",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769231_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"metoclopramide\" outputclass=\"int-drug\">Metoclopramide</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Metoclopramide   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoclopramide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769232",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769232_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"mivacurium\" outputclass=\"int-drug\">mivacurium</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  mivacurium  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mivacurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769233",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769233_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"mometasone\" outputclass=\"int-drug\">Mometasone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Mometasone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mometasone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769234",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769234_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"neomycin\" outputclass=\"int-drug\">neomycin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  neomycin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Neomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769235",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769235_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"pancuronium\" outputclass=\"int-drug\">pancuronium</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  pancuronium  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pancuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769236",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769236_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"paroxetine\" outputclass=\"int-drug\">Paroxetine</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Paroxetine   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Paroxetine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769237",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769237_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"phenytoin\" outputclass=\"int-drug\">Phenytoin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Phenytoin   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Phenytoin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769238",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769238_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"piperacillin\" outputclass=\"int-drug\">Piperacillin</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Study",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Piperacillin   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Piperacillin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769239",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769239_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"polymyxins\" outputclass=\"int-drug\">polymyxins</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  polymyxins  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Polymyxins</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769240",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769240_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"prednisolone\" outputclass=\"int-drug\">Prednisolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Prednisolone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Prednisolone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769241",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769241_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-drug\">Rivastigmine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rivastigmine   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rivastigmine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769242",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769242_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"rocuronium\" outputclass=\"int-drug\">rocuronium</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  rocuronium  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rocuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769243",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769243_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Unknown\" outputclass=\"int-message\">\n  <ph otherprops=\"sertraline\" outputclass=\"int-drug\">Sertraline</ph> <ph outputclass=\"int-effectQualifier\">potentially</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of prolonged neuromuscular blockade when given with</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Unknown",
							"hasOrder": "1",
							"hasTextContent": "Sertraline   potentially   increases   the risk of prolonged neuromuscular blockade when given with   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sertraline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769244",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769244_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"streptomycin\" outputclass=\"int-drug\">streptomycin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  streptomycin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Streptomycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769245",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769245_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph> and <ph otherprops=\"tobramycin\" outputclass=\"int-drug\">tobramycin</ph> have neuromuscular blocking effects.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  suxamethonium  and  tobramycin  have neuromuscular blocking effects. \n\n"
						}
					],
					"hasOrder": "47",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tobramycin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769246",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/suxamethonium#bnf_i1557280769246_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph otherprops=\"triamcinolone\" outputclass=\"int-drug\">Triamcinolone</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-heading-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Triamcinolone   is predicted to   decrease   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "48",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Triamcinolone</title>"
					}
				}
			],
			"hasSearchLabel": " Suxamethonium  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/suxamethonium.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Suxamethonium </title>"
			},
			"rdfs:label": "suxamethonium"
		}
	]
}